Genetic Technologies' Q1 Revenues Halved | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies' fiscal 2013 first-quarter revenues dropped 50 percent year over year, the Australian firm said today in a regulatory document.

For the three months ended Sept. 30, GTG posted A$1.2 million (US$1.2 million) in receipts, down from A$2.4 million a year ago. Its loss for the quarter rose 69 percent to A$2.2 million from A$1.3 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.